These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16284525)

  • 1. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin.
    Pusch O; Boden D; Hannify S; Lee F; Tucker LD; Boyd MR; Wells JM; Ramratnam B
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):512-20. PubMed ID: 16284525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered intravaginal isolate of Lactobacillus plantarum expresses algal lectin scytovirin demonstrating anti-HIV-1 activity.
    Janahi EMA; Haque S; Akhter N; Wahid M; Jawed A; Mandal RK; Lohani M; Areeshi MY; Almalki S; Das S; Dar SA
    Microb Pathog; 2018 Sep; 122():1-6. PubMed ID: 29870744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N.
    Liu X; Lagenaur LA; Simpson DA; Essenmacher KP; Frazier-Parker CL; Liu Y; Tsai D; Rao SS; Hamer DH; Parks TP; Lee PP; Xu Q
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3250-9. PubMed ID: 17005802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
    Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
    J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).
    Gandhi MJ; Boyd MR; Yi L; Yang GG; Vyas GN
    Dev Biol (Basel); 2000; 102():141-8. PubMed ID: 10794101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus plantarum extracellular chitin-binding protein and its role in the interaction between chitin, Caco-2 cells, and mucin.
    Sánchez B; González-Tejedo C; Ruas-Madiedo P; Urdaci MC; Margolles A
    Appl Environ Microbiol; 2011 Feb; 77(3):1123-6. PubMed ID: 21131525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes.
    Balzarini J; Van Laethem K; Peumans WJ; Van Damme EJ; Bolmstedt A; Gago F; Schols D
    J Virol; 2006 Sep; 80(17):8411-21. PubMed ID: 16912292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion and functional expression of Mycobacterium bovis antigens MPB70 and MPB83 in lactic acid bacteria.
    Stedman A; Chambers MA; Gutierrez-Merino J
    Tuberculosis (Edinb); 2019 Jul; 117():24-30. PubMed ID: 31378264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic pathway engineering in lactic acid bacteria.
    Kleerebezem M; Hugenholtz J
    Curr Opin Biotechnol; 2003 Apr; 14(2):232-7. PubMed ID: 12732327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unity in organisation and regulation of catabolic operons in Lactobacillus plantarum, Lactococcus lactis and Listeria monocytogenes.
    Andersson U; Molenaar D; Rådström P; de Vos WM
    Syst Appl Microbiol; 2005 Apr; 28(3):187-95. PubMed ID: 15900965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of the HIV-1 microbicide cyanovirin-N in a food product.
    Li M; Patton DL; Cosgrove-Sweeney Y; Ratner D; Rohan LC; Cole AM; Tarwater PM; Gupta P; Ramratnam B
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):379-84. PubMed ID: 21926631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
    Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
    Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli.
    Cortes-Perez NG; Azevedo V; Alcocer-González JM; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P; Bermúdez-Humarán LG
    J Drug Target; 2005 Feb; 13(2):89-98. PubMed ID: 15823960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanovirin-N produced in rice endosperm offers effective pre-exposure prophylaxis against HIV-1BaL infection in vitro.
    Vamvaka E; Evans A; Ramessar K; Krumpe LR; Shattock RJ; O'Keefe BR; Christou P; Capell T
    Plant Cell Rep; 2016 Jun; 35(6):1309-19. PubMed ID: 27007716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
    Wyszyńska A; Kobierecka P; Bardowski J; Jagusztyn-Krynicka EK
    Appl Microbiol Biotechnol; 2015 Apr; 99(7):2967-77. PubMed ID: 25750046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent.
    Huskens D; Vermeire K; Vandemeulebroucke E; Balzarini J; Schols D
    Int J Biochem Cell Biol; 2008; 40(12):2802-14. PubMed ID: 18598778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts.
    Mori T; Barrientos LG; Han Z; Gronenborn AM; Turpin JA; Boyd MR
    Protein Expr Purif; 2002 Oct; 26(1):42-9. PubMed ID: 12356469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous expression of glycoside hydrolase family 2 and 42 β-galactosidases of lactic acid bacteria in Lactococcus lactis.
    Schwab C; Sørensen KI; Gänzle MG
    Syst Appl Microbiol; 2010 Oct; 33(6):300-7. PubMed ID: 20822875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.